New data indicate that the global annual prevalence of pressure ulcers in SCI-persons is 32.4% (Shiferaw et al. 2020). When a pressure ulcer is severe and not treated aggressively it can lead to further disability (e.g., reduced mobility, dependence, surgical intervention, amputation, fatal infection; Krause 1998). It has…
Pyoderma gangrenosum (PG) is a rare neutrophilic inflammatory condition. It is characterised by painful, rapidly expanding, violaceous, undermined ulcers. Immunosuppressants are key to management, but large chronic ulcers often result. University Hospital Birmingham, UK, evaluated MPPT in three patients with chronic inactive stable PG ulcers. The patients were…
Amicapsil was evaluated in a clinical audit at Bristol University Hospital on 9 dehisced surgical wounds and a category 4 pressure ulcer. Several of the wounds displayed more than 40% slough and signs of local infection. Amicapsil rapidly lifted the slough off and facilitated a rapid build-up of…
See publication in WOUNDS here. Objective The purpose of the study was to evaluate the wound healing effects of MPPT and to compare it to antibiotics and antiseptics. The study included a wide range of wounds and ulcers, which were severely colonised to infected. The comparators were a…